Researchers at the University of Saskatchewan and the Saskatchewan Cancer Agency are in the process of making a major step into a potential breast cancer treatment.
Dr. Andrew Freywald, a researcher at the College of Medicine, and Dr. Franco Vizeacoumar from the Saskatchewan Cancer Agency recently made a discovery into the most aggressive breast cancer type, triple-negative breast cancer.
Their research found that they can target a gene called S-R-C to eliminate a certain strain of breast cancer cells and tumours that lack a certain molecule.
Vizeacoumarsays the discovery is the highlight of a three year partnership between the cancer agency and the university.
The team is now seeking funding to conduct clinical trials, which they are hoping to conduct in the next two years.
It would be the first cancer-related investigation going from the beginning to trial within Saskatchewan.